MAPS’ 2024 Benchmark Report is based on findings from 32 organizations in Pharma and MedTech and reflects broad leadership thinking about the current and future states of AI capabilities and challenges in Medical Affairs.
Share of Voice used to be a numbers game to increase sales and market share. But with the advent of the digital age, Share of Voice has come to mean more than just numbers.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
Download the new Dimensions White Paper to discover the current and emerging research trends in Pharma.
This White Paper ranks social media platforms, demonstrates how life science companies are adapting to the digital world, defines the digital opinion leader and how to find one, and provides 4 key takeaways that you can start implementing right away.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
This white paper addresses insights challenges in Strategy, Data Generation, and Analysis/Reporting – arming Medical Affairs teams with the tools and opportunity to build strategies that preempt these challenges.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.